SUMITOMO PHARMA CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 407 JPY | +7.96% |
|
+13.06% | -12.66% |
| May. 07 | Profit-Taking, China Outlooks Churn Asian Stock Markets | MT |
| May. 02 | Fed Outlook, Earnings Season Roil Asian Stock Markets | MT |
ETFs positioned on Sumitomo Pharma Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.38% | 0 M€ | +10.90% | ||
| 0.15% | 0 M€ | +15.03% | ||
| 0.13% | 0 M€ | +15.12% | - | |
| 0.11% | 0 M€ | +3.32% | ||
| 0.10% | 0 M€ | +14.13% | - | |
| 0.06% | 0 M€ | +18.00% | ||
| 0.06% | 0 M€ | +16.70% | ||
| 0.05% | 0 M€ | +17.82% | ||
| 0.05% | 0 M€ | +16.56% | ||
| 0.03% | 0 M€ | +16.36% | ||
| 0.03% | 0 M€ | +16.73% | ||
| 0.03% | 0 M€ | +15.35% | - | |
| 0.02% | 0 M€ | +15.14% | - | |
| 0.02% | 0 M€ | +16.23% | ||
| 0.02% | 0 M€ | +16.32% | - | |
| 0.01% | 0 M€ | -.--% | - | |
| 0.01% | 0 M€ | +4.65% | - | |
| 0.00% | 0 M€ | +6.98% | - | |
| 0.00% | 10 M€ | -3.35% | - | |
| 0.00% | 0 M€ | +7.83% | - | |
| 0.00% | 0 M€ | +8.19% | - | |
| 0.00% | 0 M€ | +5.29% | - | |
| 0.00% | 0 M€ | +5.52% | - | |
| 0.00% | 0 M€ | +3.48% | - |
Sumitomo Pharma Co., Ltd. (formerly Sumitomo Dainippon Pharma Co., Ltd.) specializes in development, manufacturing and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceuticals (92.9%): for cardiovascular, gastrointestinal and infectious diseases, central nervous systems disorders and allergies treatment;
- other (7.1%): veterinary drugs, food additives, industrial chemical products, etc.
Net sales are distributed geographically as follows: Japan (39.8%), the United States (50.4%), North America (0.9%) and other (8.9%).
Sector
Pharmaceuticals
Calendar
2024-05-13
- Q4 2023 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
8
Last Close Price
377
JPY
Average target price
333.8
JPY
Spread / Average Target
-11.47%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.66% | 927M | |
| +32.36% | 698B | |
| +26.51% | 568B | |
| -4.40% | 358B | |
| +19.46% | 328B | |
| +3.50% | 283B | |
| +16.34% | 238B | |
| +6.68% | 203B | |
| -9.08% | 198B | |
| +8.62% | 165B |
- Stock Market
- Equities
- 4506 Stock
- Funds and ETFs Sumitomo Pharma Co., Ltd.